Diamyd Medical AB (publ) (STO:DMYD.B)

Diamyd Medical AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is September - August.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 10, 2026	Aug 31, 2025	Aug 31, 2024	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021
Market Capitalization	178	1,554	1,637	840	1,122	2,412
Market Cap Growth	-85.81%	-5.11%	94.98%	-25.12%	-53.50%	-11.83%
Enterprise Value	-13	1,234	1,475	762	929	2,218
Last Close Price	1.15	11.30	16.42	9.79	14.24	32.90
PE Ratio	-	-	-	-	-	40.17
Forward PE	-	129.14	-	-	-	-
PS Ratio	491.50	11951.90	12595.78	1538.11	2470.47	9533.21
PB Ratio	1.05	5.55	11.22	4.96	5.23	12.74
P/TBV Ratio	1.05	5.55	11.22	4.96	5.23	12.75
EV/Sales Ratio	-	9496.04	11346.68	1396.51	2045.78	8765.65
Net Debt / Equity Ratio	-1.12	-0.99	-0.91	-0.75	-0.74	-0.74
Net Debt / EBITDA Ratio	0.95	1.57	0.93	1.15	1.44	1.63
Net Debt / FCF Ratio	1.12	1.54	0.97	1.04	1.25	1.23
Asset Turnover	0.00	0	0.00	0.00	0.00	0.00
Quick Ratio	4.74	10.25	3.41	6.66	7.59	12.37
Current Ratio	4.83	10.64	3.98	7.09	8.10	14.29
Return on Equity (ROE)	-142.52%	-79.72%	-96.32%	-60.49%	-51.29%	45.88%
Return on Assets (ROA)	-59.98%	-40.21%	-43.54%	-32.74%	-32.80%	-36.95%
Return on Capital Employed (ROCE)	-98.00%	-56.40%	-83.20%	-62.30%	-53.40%	-45.30%
Earnings Yield	-112.67%	-10.93%	-9.27%	-13.82%	-9.23%	2.49%
FCF Yield	-95.77%	-11.57%	-8.38%	-14.57%	-11.40%	-4.71%
Buyback Yield / Dilution	-28.78%	-18.81%	-20.98%	-2.29%	-9.65%	-0.90%

Data Source: S&P Global Market Intelligence Last updated: Feb 28, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 11, 2026

Data Sources Report a data error